1 ith the visceralizing species of Leishmania, Leishmania chagasi.

2 vironment surrounding the invading protozoan Leishmania chagasi.

3 fore, we investigated protective immunity to Leishmania chagasi, a cause of visceral leishmaniasis.

4  efficiently inhibited the in vivo growth of Leishmania chagasi and Leishmania amazonensis promastigo

5 to a cloned antigen, recombinant (r) K39, of Leishmania chagasi are specific for members of the Leish

6                                              Leishmania chagasi causes visceral leishmaniasis and, to

7 ssue cytokine response of dogs infected with Leishmania chagasi, cytokine mRNA levels were measured i

8 crapings from cutaneous leishmanial lesions, Leishmania chagasi in dermal scrapings of atypical cutan

9 sness of 50 sentinel dogs exposed to natural Leishmania chagasi infection was assessed through time b

10 B/c bone marrow macrophages with and without Leishmania chagasi infection.

11 l leishmaniasis (VL) caused by the protozoan Leishmania chagasi is ongoing outside Natal, northeast B

12                                              Leishmania chagasi) parasite in the gut, but the extent

13 te level of GP46 mRNA increases >>30-fold as Leishmania chagasi promastigotes develop in vitro from a

14 ly, resulting in about a 30-fold increase as Leishmania chagasi promastigotes grow in vitro from loga

15        Monocytes infected with MBL-opsonized Leishmania chagasi promastigotes secreted higher levels

16 ectants, we developed a method to label live Leishmania chagasi short-term with fluorescent dyes.

17                                              Leishmania chagasi, the cause of South American visceral

18 ry from the intracellular amastigote form of Leishmania chagasi, the cause of South American visceral

19                 The ability of the protozoan Leishmania chagasi to infect a vertebrate host depends o

20 nerates superoxide and hydrogen peroxide, on Leishmania chagasi virulence.